Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Burkitt Lymphoma 12Prostatic Neoplasms 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Large B-Cell, Diffuse 4Plasmablastic Lymphoma 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Follicular 2Immunoblastic Lymphadenopathy 2Enteropathy-Associated T-Cell Lymphoma 2Neuroblastoma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Melanoma 1Lymphoma, Primary Effusion 1Lymphoma, B-Cell 1Lymphoma, AIDS-Related 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Hormone-Resistant Prostate Cancer 1Hodgkin Disease 1Hematologic Neoplasms 1HIV Infections 1Composite Lymphoma 1Carcinoma, Merkel Cell 1Carcinoma, Basal Cell 1Blast Crisis 1

Interventions

fludarabine phosphate 15Cyclophosphamide 13Whole-Body Irradiation 12Peripheral Blood Stem Cell Transplantation 12Tacrolimus 10Etoposide 10Rituximab 8Mycophenolic Acid 8Methotrexate 6Melphalan 6Cyclosporine 6Busulfan 6Antilymphocyte Serum 6Vorinostat 4Sirolimus 4Prednisone 4Lenalidomide 4Immunohistochemistry 4Gene Expression Profiling 4Carboplatin 4Vincristine 3Microarray Analysis 3Gemcitabine 3Everolimus 3Doxorubicin 3Dexamethasone 3Brentuximab Vedotin 3Alemtuzumab 310-propargyl-10-deazaaminopterin 3thymoglobulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Immunoblastic Lymphadenopathy × deltacortene × Clear all
NCT03113500 2025-11-14

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma

City of Hope Medical Center

Phase 2 Active not recruiting
48 enrolled 8 charts
LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Enteropathy-Associated T-Cell Lymphoma

NCT02561273 2023-12-13

Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma

University of Nebraska

Phase 1/2 Completed
54 enrolled 14 charts
Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡